$32.34-0.73 (-2.21%)
Invesco Ltd.
Invesco Ltd. in the Financial Services sector is trading at $32.34 with a market capitalization of $14.3B. Wall Street consensus targets $33.38 (12 analysts), implying a +3.2% move over the next 12 months. The stock is currently near its 52-week high of $33.66, remaining 20.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.83B↑ | $1.74B↑ | $1.69B↑ | $1.64B↑ | $1.52B |
| Gross Profit | $651.80M↑ | $630.40M↑ | $626.70M↑ | $560.50M↑ | $504.40M |
| Operating Income | $364.20M↑ | $333.20M↑ | -$1.46B↓ | $270.90M↑ | $214.20M |
| Net Income | $382.30M↑ | $268.60M↑ | -$1.06B↓ | $345.70M↑ | $203.40M |
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension fu...

Four monthly ETFs are clearing 11% yields to start 2027, but the engines manufacturing that income are wildly different, and picking the wrong one for your situation could leave you trading principal for paychecks.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Invesco (IVZ) have what it takes? Let's find out.

Style Box ETF report for RPV

Hargreaves Lansdown finally sells Bitcoin, but its clients missed Britain's 180-day window to keep the profits tax-free.

Invesco (IVZ) demonstrates strong technical momentum, with shares up more than 50% over the past year. Shares are trading near a new 5-year high. Analyst sentiment is positive, with multiple “Buy” ratings and price targets ranging from $29 to $50, and a consensus near $34. IVZ’s diversified product suite spans...
Academic risk and quality models computed from IVZ's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 34.5% reading.
Fama-French 5-factor market beta. The five factors explain 47% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.